866-997-4948(US-Canada Toll Free)

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Medical Devices Pipeline Assessment, 2019

Published By :

GlobalData

Published Date : Dec 2019

Category :

Medical Equipments

No. of Pages : 211 Pages

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview 12
3 Products under Development 13
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 13
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment 14
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 15
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 16
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 17
3.6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 18
4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products under Development by Companies 19
4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development 19
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 21
5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview 23
5.1 Andramed GmbH Company Overview 23
5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
5.2 AnGes Inc Company Overview 24
5.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 AngioCure, Inc. Company Overview 25
5.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Boston Scientific Corp Company Overview 26
5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Cagent Vascular LLC Company Overview 33
5.5.1 Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.6 Cardionovum GmbH Company Overview 36
5.6.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Cardiovascular Systems Inc Company Overview 39
5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.8 Concept Medical Inc Company Overview 40
5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 Contego Medical LLC Company Overview 43
5.9.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Endocor GmbH Company Overview 45
5.10.1 Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview 45
5.11 eucatech AG Company Overview 46
5.11.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 46
5.12 Hexacath SA Company Overview 47
5.12.1 Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview 47
5.13 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 48
5.13.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.14 Lutonix Inc Company Overview 51
5.14.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.15 M.A. Med Alliance SA Company Overview 56
5.15.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 56
5.16 Medtronic plc Company Overview 57
5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 57
5.17 Micell Technologies Inc Company Overview 61
5.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview 62
5.18.1 MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 NuVascular Technologies Inc Company Overview 65
5.19.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.20 Orchestra BioMed Inc Company Overview 66
5.20.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 66
5.21 Pulsus Medical LLC (Inactive) Company Overview 67
5.21.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67
5.22 QT Vascular Ltd Company Overview 68
5.22.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
5.23 QualiMed Innovative Medizinprodukte GmbH Company Overview 72
5.23.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 72
5.24 SiL Vascular Ltd Company Overview 73
5.24.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
5.25 Spectranetics Corp Company Overview 74
5.25.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 74
5.26 SurModics Inc Company Overview 81
5.26.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 81
5.27 Tailored Medical Devices Inc Company Overview 90
5.27.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 90
5.28 TransMed7 LLC Company Overview 91
5.28.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 91
5.29 Vascular Nanotransfer Technologies Company Overview 92
5.29.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 92
5.30 Zhejiang Zylox Medical Device Co Ltd Company Overview 94
5.30.1 Zhejiang Zylox Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments 95
6.1 Nov 22, 2019: Medtronic receives FDA approval for IN.PACT AV DCB 95
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 95
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 98
6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 99
6.5 Nov 12, 2019: Cook Medicals leadership updates in Asia-pacific reinforce focus on growth and physician relationships 99
7 Appendix 208
7.1 Methodology 208
7.2 About GlobalData 211
7.3 Contact Us 211
7.4 Disclaimer 211

List of Tables
Table 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment
Table 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
Table 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
Table 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Table 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials
Table 7: PTA Balloons Catheters Companies - Pipeline Products by Stage of Development
Table 8: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Table 9: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Zero-Profile PTA Balloon - Product Status
Table 11: Zero-Profile PTA Balloon - Product Description
Table 12: AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
Table 14: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
Table 15: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: AngioCure TOP-C Smart Balloon Catheter - Product Status
Table 17: AngioCure TOP-C Smart Balloon Catheter - Product Description
Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Athletis PTA Balloon - Product Status
Table 20: Athletis PTA Balloon - Product Description
Table 21: Drug Coated Balloon - Below-The-Knee (BTK) - Product Status
Table 22: Drug Coated Balloon - Below-The-Knee (BTK) - Product Description
Table 23: High Pressure Balloon - Venous Disease - Product Status
Table 24: High Pressure Balloon - Venous Disease - Product Description
Table 25: Next Generation 0.018 Balloon - Product Status
Table 26: Next Generation 0.018 Balloon - Product Description
Table 27: Ranger Drug-Coated Balloon - Product Status
Table 28: Ranger Drug-Coated Balloon - Product Description
Table 29: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 30: Ranger Drug-Coated Balloon - A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis
Table 31: Ranger Drug-Coated Balloon - Clinical Study of the Boston Scientific Paclitaxel-coated PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter (Ranger and Ranger SL (OTW) DCB) in China
Table 32: Ranger Drug-Coated Balloon - JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
Table 33: Ranger Drug-Coated Balloon - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
Table 34: Ranger Drug-Coated Balloon - Prospective, Randomized, Multicenter Clinical Study of the Hemoteq Ranger Paclitaxel-coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions
Table 35: Ranger Drug-Coated Balloon - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
Table 36: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Serranator Bass - Product Status
Table 38: Serranator Bass - Product Description
Table 39: Cagent Vascular LLC - Ongoing Clinical Trials Overview
Table 40: Serranator Bass - Prospective Study for the Treatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Using the Serranator Device: PRELUDE BTK (Below The Knee) Study
Table 41: Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 42: APERTO OTW - Product Status
Table 43: APERTO OTW - Product Description
Table 44: Cardionovum GmbH - Ongoing Clinical Trials Overview
Table 45: APERTO OTW - A Randomized Trial of Aperto Paclitaxel Eluting Dilatation Catheter Compared to POBA in Dialysis Fistula
Table 46: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Peripheral PTA Balloon Catheter - Product Status
Table 48: Peripheral PTA Balloon Catheter - Product Description
Table 49: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: MagicTouch PTA Balloon Catheter - Product Status
Table 51: MagicTouch PTA Balloon Catheter - Product Description
Table 52: Concept Medical Inc - Ongoing Clinical Trials Overview
Table 53: MagicTouch PTA Balloon Catheter - A Pilot Study to Evaluate the Safety and Efficacy of MagicTouch PTA Sirolimus Coated Balloon for the Treatment of Below-the-Knee (BTK) Lesions
Table 54: Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Superficial Femoral Artery Balloon - Product Status
Table 56: Superficial Femoral Artery Balloon - Product Description
Table 57: Tibial Artery Drug Eluting Balloon - Product Status
Table 58: Tibial Artery Drug Eluting Balloon - Product Description
Table 59: Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Endorenal - Product Status
Table 61: Endorenal - Product Description
Table 62: eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Support - Product Status

List of Figures
Figure 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Segment
Figure 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
Figure 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
Figure 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Figure 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *